In 2024, Samsung Biologics posted a net profit of around 1.1 trillion South Korean won. Samsung Biologics is a pharmaceutical company of Samsung Group and produces biopharmaceuticals for global companies. Biotech and health sector are among the key growth engine industries of Samsung Group.
Net profit of Samsung Biologics from 2015 to 2024
(in billion South Korean won)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DART. (March 6, 2025). Net profit of Samsung Biologics from 2015 to 2024 (in billion South Korean won) [Graph]. In Statista. Retrieved June 06, 2025, from https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART. "Net profit of Samsung Biologics from 2015 to 2024 (in billion South Korean won)." Chart. March 6, 2025. Statista. Accessed June 06, 2025. https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART. (2025). Net profit of Samsung Biologics from 2015 to 2024 (in billion South Korean won). Statista. Statista Inc.. Accessed: June 06, 2025. https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART. "Net Profit of Samsung Biologics from 2015 to 2024 (in Billion South Korean Won)." Statista, Statista Inc., 6 Mar 2025, https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
DART, Net profit of Samsung Biologics from 2015 to 2024 (in billion South Korean won) Statista, https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/ (last visited June 06, 2025)
Net profit of Samsung Biologics from 2015 to 2024 (in billion South Korean won) [Graph], DART, March 6, 2025. [Online]. Available: https://www.statista.com/statistics/1165974/samsung-biologics-net-profit/
